MI, the infarct begins to mature into a dense scar. 6 We have recently demonstrated that canonical Wnt signaling activation after MI attenuates fibrosis and promotes arteriole formation and cardiogenesis, suggesting that developmental pathways, critical for embryonic cardiac development, are reactivated after injury in the adult heart to regulate tissue repair. 7, 8 Bone morphogenetic proteins (BMPs) play important roles during various stages of cardiac development, 9 including early cardiogenic differentiation of mesoderm, 10 cardiac tube assembly, looping and jogging, 11 cardiac chamber identity, 12 cardiomyocyte differentiation, 13 and cardiac cushion formation.
14 BMP signaling is also induced after ischemic injury in the adult mouse heart and implicated in cardiomyocyte apoptosis during ischemia/reperfusion. 15, 16 Histological analyses showed strong induction of Bmp2 in peri-infarct cardiomyocytes 17 ; however, the exact role of BMP signaling in cardiac tissue repair, or how BMP signaling is regulated after cardiac injury, is not well understood.
BMPs belong to the transforming growth factor β (TGFβ) superfamily of secreted ligands and bind to type I and type II receptors as dimers, leading to phosphorylation and activation of the type I receptor by its type II partner. Activated type I receptors then phosphorylate Smad1/5/8 intracellular proteins, which complex with Smad4 and translocate to the nucleus, where they regulate expression of target genes such as the Id family of transcriptional repressors. 18 BMP signaling is modulated in the extracellular space by a large number of secreted, structurally diverse antagonists, such as Chordin, Noggin and members of the DAN family, that bind to BMP ligands and thereby hinder binding to the corresponding receptors. 19, 20 Gremlin 2 (Grem2), also called protein related to Dan and Cerberus, belongs to the DAN family of BMP antagonists together with its close paralog Gremlin 1, Dan, Dante (or Coco), Cerberus-like 1, Uterine sensitization-associated gene-1, and Sclerostin. [21] [22] [23] Grem2 was first discovered 15 years ago, 21 but its biological function and mechanism of BMP inhibition have remained largely obscure. Grem2 expression has been detected in the developing spinal cord and lung mesenchyme, 24, 25 and Grem2 has been implicated in follicle, neuronal, and bone development. [26] [27] [28] Grem2 in vitro inhibits Bmp2 and Bmp4 but not Tgfβ or activin. 26 Although several DAN-family members, such as Dante and Grem1, have been linked to pulmonary arterial hypertension, chronic kidney disease, and cancer, [29] [30] [31] [32] little is known about the role of Grem2 in disease.
We recently established that during embryonic development in zebrafish, grem2 first appears in the pharyngeal mesoderm next to the forming heart tube. 33, 34 Loss-and gainof-function approaches demonstrated that Grem2 is necessary for cardiac tube jogging and looping, cardiac laterality, and cardiomyocyte differentiation by suppression of Smad1/5/8 phosphorylation. 34 Moreover, we found that Grem2 promotes differentiation of pluripotent mouse embryonic stem cells to atrial-like cardiomyocytes. 35 Here, we show that Grem2 is not essential for mouse embryonic development. In the adult heart, we discovered that Grem2 is highly induced in peri-infarct cardiomyocytes at the end of the inflammatory phase after MI. Using genetic gain-and loss-of-Grem2-function models and chemical compounds that inhibit BMPs, we present evidence that Grem2 is necessary and sufficient to modulate the inflammatory response and keep inflammation in check through suppression of canonical BMP signaling. Grem2 levels after MI correlate with functional recovery, suggesting a new strategy to control inflammation of cardiac tissue after acute ischemic injury and improve cardiac function.
Methods
A complete Methods section is available in the Online Data Supplement.
Results

Grem2 Is Transiently Induced After MI After the Initial Inflammatory Response
To place BMP-signaling components within the context of the MI repair process, we analyzed whole mouse heart RNA samples prepared at distinct time points after left anterior descending artery ligation, namely at days 0 (baseline, prior to injury), 1, 2, 3, 5, 7, and 21 after MI. Using typical inflammatory gene markers, such as Il-1β and E-selectin, and markers of granulation tissue formation and fibrosis, such as Tgfβ1 and α-Smooth muscle actin (αSma), we determined that proinflammatory genes are induced early and peak at days 1 to 2 after MI, whereas fibrosis genes are induced at day 5, as expected. 4, 6, 8 Gene induction of inflammatory genes returned to baseline levels between days 3 and 5, whereas Tgfβ1 expression returned to baseline at day 21. αSma levels declined but were still detectable at day 21, reflecting the presence of myofibroblasts during the scar maturation phase ( Figure 1A) .
Investigation of BMP ligands after MI showed that Bmp2 is the earliest induced ligand of the BMP family at day 1 with its expression peaking at day 3, a pattern that corresponds to the inflammatory phase of cardiac repair. Previous work documented that Bmp2 protein induction takes place primarily in peri-infarct area cardiomyocytes and not in recruited immune cells. 17 Bmp2 is then downregulated to preinjury levels by day 7 after MI. Bmp2 suppression coincides with upregulation of Bmp4, Bmp6, and Bmp10, the expression of which starts around day 5, and persists during fibrosis and scar formation ( Figure 1B) . Consistent with the induction of distinct BMP ligands during different stages after MI, there was an overlapping expression of the BMP-signaling target gene Id2 throughout the repair process (Online Figure IA) . In contrast, analysis of BMP-signaling antagonists showed minimal changes in their expression levels after MI with the notable exception of Grem2 that is induced around day 2, peaks at day 5 after MI, and returns to preinjury levels at day 21 ( Figure 1C ). The Grem2 induction pattern follows the pattern of Bmp2 with 1-day delay. We did not detect a
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July 22, 2016 signal for its close paralog Grem1 at baseline or at the tested time points after MI (Online Figure IB) . Although Grem2 is the most prominently induced BMP antagonist after MI, absolute expression values indicate that during homeostasis, the heart maintains expression of Dan, Sost, Twsg1, and Chordin, which, however, are at least 40 (Chordin) to 400 (Dan and Twsg1) times less potent BMP inhibitors than Grem2 or do not bind directly to BMP ligands (Sost) (Online Figure IB) . 36, 37 Consistent with the Bmp2 induction pattern after MI, immunofluorescence analysis at day 2 post MI, using antibodies recognizing the phosphorylated, that is, activated form of Smad1/5/8, demonstrated the activation of canonical BMP signaling in endothelial cells in the peri-infarct area and cardiomyocytes at the border zone of the infarcted tissue. In contrast, we did not detect active Smad1/5/8 within ventricular tissue prior to injury ( Figure 1D ).
In conclusion, our data indicate a biphasic pattern of BMP ligand induction after MI, that is, early upregulation of Bmp2 expression during the inflammatory phase, followed by a second phase during granulation tissue and scar formation that is dominated by several ligands, including Bmp4, Bmp6, and Bmp10. Conversely, Grem2 is the prominent BMP antagonist induced after MI with its expression starting at day 2, peaking during the transition from inflammation to granulation tissue formation, and returning to baseline levels during scar formation. Induction of Bmp2 coincided with activation of canonical/p-Smad BMP signaling in endothelial cells and cardiomyocytes in the periinfarct area. . A-C, Whole mouse heart RNA samples were isolated at days 0 (baseline, before injury), 1, 2, 3, 5, 7, and 21 post MI and analyzed by quantitative polymerase chain reaction. Values at baseline were set as 1. A, Sequential induction of inflammation-(Il-1β and E-selectin) and fibrosis-(Tgfβ1 and αSma) associated genes after MI. B, Expression analysis of BMP ligands shows that Bmp2 is transiently induced during the inflammatory phase of the post-MI repair process, followed by induction of Bmp4, Bmp6, and Bmp10. C, Expression analysis of BMP antagonists shows that Gremlin 2 (Grem2) is the main antagonist induced after MI, starting at the late inflammatory phase and peaking at day 5. *P<0.05, **P<0.01, and ***P<0.001 compared with day 0. One-way ANOVA with Dunnett multiple comparisons test. n=3 for all time points. All data are presented as mean±SEM. D, Immunofluorescence (IF) analysis with antibodies recognizing p-Smad1/5/8 (green) and CD31 (red) shows that p-Smad1/5/8 is not present in normal cardiac tissue at baseline before MI but is activated in peri-infarct area endothelial cells at day 2 post MI (representative examples marked with arrows) and in cardiomyocytes (asterisks). DAPI (blue) marks cellular nuclei. Scale bar, 50 μm. αSma indicates α-Smooth muscle actin; BZ, border zone; Dan, Neuroblastoma 1 (Nbl1); Dand5, DAN domain family member 5 (also Dante, or Coco); Grem2, Gremlin 2; Il-1β, Interleukin 1β; INF, infarct; Sost, Sclerostin; Tgfβ1, Transforming growth factor-β1; and Twsg1, Twisted gastrulation BMP-signaling modulator 1.
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Loss of Grem2 Leads to an Increase of Endothelial Proinflammatory Markers After MI
To determine whether Grem2 has a role in cardiac repair, we generated a loss of function (Grem2 −/− mice are viable without major structural or physiological defects or apparent differences in heart size, cardiac tissue morphology, and cardiac function when compared with wildtype (WT) siblings, with the exception of a small increase in heart rate (Online Table I ; Online Figure II) . Thus, although the Grem2 expression pattern has been conserved in zebrafish and mouse embryos, where Grem2 is first expressed in the area of the secondary heart field, 34, 35 Grem2 seems to be dispensable for mouse development.
Antibody staining revealed that the robust induction of Grem2 protein after MI takes place primarily in peri-infarct cardiomyocytes ( Figure 2B ). There was no detected Grem2 in distal areas away from the infarct (data not shown). There was also a complete absence of Grem2 protein in Grem2 −/− mice, further corroborating their null phenotype ( Figure 2B ).
To test whether the Grem2 induction after the upregulation of Bmp2 expression during the inflammatory phase plays a role in inflammation after acute injury, we challenged Grem2 −/− and WT sibling mice with experimental MI by permanent ligation of the left anterior descending coronary artery. We then isolated whole-heart RNA at days 0, 2, 7, and 21 after MI and analyzed the expression of proinflammatory genes. Our data show that induction of genes encoding endothelial cell membrane proteins implicated in the rolling and adhesion of circulating immune cells to the vascular wall are higher in Grem2 −/− hearts compared with WTs. Specifically, RNA analysis showed that expression of E-selectin, Vcam1, and Icam1 are further upregulated compared with WT controls at days 2 and 7 after MI; however, their expression decreases at day 21 to levels comparable with WT hearts ( Figure 2C) .
Consistent with the gene induction results, immunofluorescence analysis of cardiac tissue sections at day 7 after MI revealed that endothelial cells within the infarct and peri-infarct areas stain positively for E-selectin protein in Grem2 −/− mice, whereas, at this stage, E-selectin is almost undetectable in WT controls ( Figure 2D ). Comparison of chemokine expression, such as Ccl2, Il-8, and Il-1β, showed that although chemokines are induced after MI as expected, relative expression levels were comparable between Grem2 −/− and WT mice, except a further 1.7-fold increase of Ccl2 expression in Grem2 −/− mice compared with WT (Online Figure IIIA) . Together, our data show that Grem2 protein induction takes place in the peri-infarct zone and lack of Grem2 enhances the expression of proinflammatory genes in endothelial cells in and around the injury site after MI.
Loss of Grem2 Leads to an Increase in the Magnitude of Inflammation
To test whether increased expression of proinflammatory makers after MI augments infiltration of immune cells, we isolated hearts at day 5 after MI and analyzed histological sections with an antibody recognizing the leukocyte marker, CD45. The results showed that infiltration of CD45 + cells after MI appeared more abundant in Grem2 −/− hearts compared with WT ( Figure 3A) . To quantify the increase in inflammatory infiltrate and better characterize the corresponding cells, we prepared single-cell suspensions of noncardiomyocyte cells and conducted flow cytometry using antibodies recognizing various immune cell markers, such as CD45, F4/80, Ly6C, Ccr2, Ly6G, and CD3. [38] [39] [40] As shown in Figure 3B Figure IV .
Analysis of the initial necrosis area using triphenyl tetrazolium chloride staining 1 day after MI showed that infarct sizes are comparable between WT and Grem2 −/− hearts, suggesting that the observed differences in the inflammatory response are not because of more severe infarcts in Grem2 −/− mice (Online Figure V) . Furthermore, flow cytometry analysis on blood CD45 + cells isolated from Grem2 −/− and WT mice at baseline and 5 days after MI revealed that leukocyte numbers in the blood were not significantly different at baseline. After MI, the number of circulating leukocytes increased as expected, 41 although numbers were ≈2× higher in Grem2 −/− mice, likely because circulating leukocyte numbers correlate with the magnitude of the inflammatory response (Online Figure VI) . 42 Finally, we investigated whether the loss of Grem2, besides increased inflammatory cell infiltration, also leads to prolonged inflammation. To this end, we quantified inflammatory cells by flow cytometry at day 14 after MI, a time point when inflammatory cell numbers return close to baseline levels in WT mice. Our results showed a dramatic drop in inflammatory cells in Grem2 −/− mice to levels comparable with WT controls (Figure 3C ), consistent with the eventual downregulation of cell adhesion molecules in Grem2 −/− hearts after MI ( Figure 2B ). Furthermore, molecular analysis indicated an increase in the induction levels of genes encoding proteins involved in the resolution of inflammation, such as Tgfβ1 and Il-10 in Grem2 −/− mice compared with WT animals, which may account for the clearing of excessive inflammatory cells in Grem2 −/− cardiac tissue ( Figure 3D ). Taken together, our results indicate that Grem2 is necessary to regulate the magnitude but not the duration of the inflammatory cell infiltration after MI.
Grem2 Overexpression Attenuates the Inflammatory Response After MI
To explore the possibility that Grem2 controls the extent of inflammation after MI, we generated a transgenic mouse line where Grem2 is postnatally overexpressed in adult cardiomyocytes under the control of regulatory elements from the α-Myosin heavy chain (Myh 6) promoter that are active in the adult heart (TG Grem2 ; Figure 4A ; Methods section in Online Data Supplement). TG Grem2 mice do not exhibit differences in cardiac morphology and function when compared with WT counterparts (Online Table II Loss of Gremlin 2 (Grem2) increases expression of genes encoding endothelial cell membrane proteins that mediate inflammatory cell recruitment after myocardial infarction (MI). A, Schematic diagram of the Grem2 gene knockout strategy before (top) and after homologous recombination (bottom). The entire coding region of Grem2 in exon 2 was replaced by the pu(Δ)TK (fusion of puromycin and truncated thymidine kinase genes)/EM7neo (kanamycin resistance gene under the synthetic bacterial EM7 promoter) selection cassette as described in the Methods section in Online Data Supplement. The location of fragments A to D used to modify the corresponding BAC (bacterial artificial chromosome) clone, the extent of homology arms, and the position of DNA probes used for screening putative Grem2 −/− embryonic stem cell clones is indicated. B, Immunofluorescence analysis with antibodies recognizing Grem2 (green) and CD31 (red) shows that Grem2 protein is induced in the peri-infarct area. Grem2 expression appears primarily in cardiomyocytes but not in CD31 + endothelial cells. Grem2 protein expression is missing in Grem2 −/− mice. DAPI marks cellular nuclei. Scale bar, 100 μm. C, Quantitative polymerase chain reaction analysis of whole-heart RNA samples isolated from wild-type (WT) and Grem2 −/− mice at days 0, 2, 7, and 21 post MI. Induction levels of genes encoding endothelial cell-specific adhesion membrane proteins E-selectin, Vascular cell adhesion molecule-1 (Vcam1), and Intercellular cell adhesion molecule-1 (Icam1) are significantly higher in 
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Grem2 and WT siblings underwent permanent left anterior descending coronary artery ligation, and whole-heart RNA was isolated at days 0, 2, and 7 after MI. Quantitative polymerase chain reaction analysis showed that gain-ofGrem2-function reduced the induction levels of inflammatory gene markers, such as E-selectin and Vcam1, after MI + (intermediate and high expression levels), and F4/80 + cells within cardiac tissue ( Figure 4C ). Attenuation of inflammation correlates with reduced induction of genes encoding the anti-inflammatory Il-10 cytokine and Tgfβ1 ( Figure 4D ). These data indicate that Grem2 overexpression reduces the magnitude of the inflammatory response after MI.
Grem2 Promotes Functional Recovery After MI
The phenotypic analysis of Grem2 −/− and TG Grem2 mice indicates that Grem2 levels are inversely related to the magnitude of inflammation after MI. Excessive inflammation has been linked to poor prognosis after MI both in animal models and human patients. [43] [44] [45] To determine the effects of Grem2 gainand loss-of-function on cardiac recovery, we compared cardiac functional parameters among WT controls and TG Grem2 and Grem2 Grem2 transgenic mice. The Grem2 cDNA coding part was cloned behind a fragment of the αMHC (Myh6) gene promoter that specifically directs expression in adult cardiomyocytes. The construct includes the polyadenylation sequences of the human growth hormone gene (hGH PA). B, Quantitative polymerase chain reaction analysis of whole-heart RNA samples isolated from wild-type (WT) and TG Grem2 mice at days 0, 2, and 7 post MI. Induction of endothelial cell-specific membrane proteins E-selectin and Vcam1 is significantly attenuated in TG Grem2 hearts compared with WT. ***P<0.001 and ****P<0.0001 (2-way ANOVA with Bonferroni multiple comparisons test). n=3 per group for all time points. All data are presented as mean±SEM. Figure 5B ). Conversely, only systolic diameters are higher in Grem2 −/− mice compared with WT mix controls. These results are consistent with the Grem2 −/− mice defects because both the magnitude and spread of inflammation have been linked to systolic dysfunction ( Figure 5B) . 4 In brief, echocardiography data indicate that Grem2 levels directly correlate with functional recovery after acute MI.
Grem2 Regulates Canonical BMP Signaling in Cardiomyocytes Next to Ischemic Areas
Grem2 is known to inhibit the canonical BMP-signaling pathway by preventing BMP ligand-mediated phosphorylation of Smad1/5/8. 35 To test whether Grem2 regulates canonical BMP signaling in the heart, we analyzed cardiac tissue sections from WT, Grem2
, and TG Grem2 mice at day 7 after MI, shortly after the peak of Grem2 expression. Immunofluorescence staining with antibodies recognizing the phosphorylated, that is, the active form of Smad1/5/8, showed that canonical BMP signaling is active in peri-infarct cardiomyocytes of WT mice, in agreement with previous reports showing that BMP ligands are expressed in this region ( Figure 6A ). 17 The intensity of pSmad1/5/8 was increased in Grem2 −/− mice and decreased in TG Grem2 hearts when compared with WTs ( Figure 6A and 6B). However, unlike the early stages after MI (Figure 1 ), we did not detect p-Smad1/5/8 in endothelial cells.
The p-Smad changes overlap with the Grem2 expression domain ( Figure 2B ) in peri-infarct area cardiomyocytes, suggesting that Grem2 acts as a barrier to limit the infiltration of inflammatory cells into neighboring, relatively healthy cardiac tissue. In agreement with this notion, we observed inflammatory cells in the peri-infarct tissue past the infarct border zone in Grem2 −/− hearts, whereas inflammatory cells were confined within the infarct area in WT controls ( Figure 6C ).
To test whether the increased inflammatory cell infiltration is because of p-Smad1/5/8 mediated signaling, we injected Grem2 −/− mice with the canonical BMP-signaling chemical inhibitor DMH1 46 (4-(6-(4-isopropoxyphenyl) pyrazolo[1,5-a]pyrimidin-3-yl)quinolone) and vehicle control (DMSO) on days 2, 3, and 4 after MI, which correspond to the peak days of inflammation. We used DMH1 because it is highly specific to canonical BMP signaling without known off-target effects, as tested in various mouse disease models. [46] [47] [48] We found that DMH1 treatment rescues the proinflammatory phenotype in Grem2 −/− mice. Flow cytometry analysis at day 5 after MI showed that treated Grem2 −/− hearts have a dramatic decrease in infiltrated CD45 + , Ly6C + , and F4/80 + cells when compared with vehicle-injected controls ( Figure 6D ).
Taken together, our data indicate that Grem2 generates a molecular barrier at the border zone between infarcted and unaffected tissue that contains both the number and spatial extent of infiltrating inflammatory cells. In the absence of Grem2, increased p-Smad-mediated BMP signaling is responsible for excessive inflammation because canonical BMP inhibition rescues the loss-of-Grem2-phenotype.
Grem2 Inhibits the Proinflammatory Effect of Bmp2 on Endothelial Cells
The data described above suggest that secretion of Grem2 protein by peri-infarct cardiomyocytes regulates the extent of inflammation by affecting directly or indirectly the proinflammatory phenotype of cardiac endothelial cells. Further gene expression analysis at various time points after MI showed that Tnfα is induced first, followed by Bmp2 and then Grem2 ( Figure 7A ). To investigate whether the sequential temporal induction patterns of the 3 genes after MI are linked, we tested the effects of TNFα, BMP2, and Grem2 on the human microvascular endothelial cell line 1 (HMEC-1). We found that TNFα induces expression of E-SELECTIN, as expected; however, it also induces BMP2, suggesting that TNFα contributes to the induction of the Bmp2 gene after MI ( Figure 7B ). BMP2 in turn induces E-SELECTIN expression in endothelial cells ( Figure 7C ). BMP2 also stimulates GREM2 expression, suggesting that BMP2 induces a negative regulatory loop to limit its own activity ( Figure 7D ).
To determine whether (1) BMP2 acts synergistically with TNFα and (2) Grem2 blocks the proinflammatory effect of BMP2 on endothelial cells, we treated human microvascular endothelial cells with TNFα, BMP2, and Grem2 in different combinations ( Figure 7E and 7F) . When protein factors are added alone, both TNFα and BMP2 induce E-SELECTIN expression. Costimulation with TNFα and BMP2 leads to E-SELECTIN induction levels higher than either factor alone, suggesting that TNFα and BMP2 have a synergistic or additive effect. Grem2 does not affect the TNFα induction of E-SELECTIN but completely inhibits the BMP2 effect. In a similar fashion, coincubation with TNFα, BMP2, and Grem2 reduces E-SELECTIN levels to those induced by TNFα treatment alone ( Figure 7E ). In accordance with its function as a canonical BMP-signaling antagonist, Grem2 blocks induction of BMP-signaling target ID2, whereas TNFα alone has no effect on ID2 expression, although it reduces the fold induction of ID2 by BMP2 (Online Figure IX) . Treating cells with the chemical inhibitor of canonical BMP-signaling DMH1 showed similar effects as Grem2, indicating that BMP2-stimulated induction of E-SELECTIN is because of activation of canonical BMP signaling ( Figure 7F) .
To test the functional significance of the modulation of proinflammatory gene expression in endothelial cells by Grem2, we performed cell adhesion assays of monocytes to endothelial cells in vitro. These assays showed that preincubation of endothelial cells with BMP2 increases adhesion of monocytes to endothelial cells and further enhances the TNFα effect. Incubation with Grem2 abolishes the BMP2 effect but not that of TNFα ( Figure 7G ). In contrast, preincubation of monocytes with BMP2 or Grem2 has no effect on their adhesion to endothelial cells (Online Figure X) . Moreover, immunofluorescence analysis of infarct areas with antibodies recognizing p-Smad1/5/8 and CD45 to determine canonical BMP-signaling activity in infiltrating inflammatory cells shows no detectable p-Smad1/5/8, that is, canonical BMP signaling in inflammatory cells, and this pattern does not change in the Grem2 −/− mice (Online Figure XI) . These data further support the idea that the primary cellular targets of Grem2 are the endothelial cells. Together, our data suggest a sequential relationship among MI-induced Tnfα, Bmp2, and Grem2, where Tnfα induces Bmp2 and Bmp2 synergizes with Tnfα to further increase the proinflammatory phenotype of endothelial cells. Grem2 induction then inhibits canonical BMP signaling and the positive effect of Bmp2 on inflammatory gene expression.
Systemic Grem2 Administration Attenuates Inflammation After MI
The results obtained in TG Grem2 mice and isolated endothelial cells suggest that Grem2 is sufficient to attenuate cardiac tissue inflammation after ischemic injury. To test whether this activity is confined to a specific time window after MI and does not depend on structural or functional changes caused by permanent Grem2 overexpression in the heart of TG Grem2 mice, we injected WT mice intraperitoneally with Grem2 protein at days 2, 3, and 4 after MI, during the critical time window of the inflammatory phase. We then isolated hearts at day 5 after MI, prepared single-cell suspensions of noncardiomyocyte cells, and performed flow cytometry using antibodies recognizing specific immune cell types. As shown in Figure  8A , there is a significant decrease in the immune cell infiltrate, namely CD45 + , Ly6C + , and F4/80 + cells, in the hearts of Grem2-injected mice when compared with saline-injected controls. These results demonstrate that the anti-inflammatory phenotype in TG Grem2 after MI can be recapitulated by systemic administration of Grem2 protein during the inflammation phase of cardiac tissue repair. In conclusion, our data support the following model of cardiac tissue repair: induction of proinflammatory cytokines such as Tnfα after MI initiates a transient inflammatory response, which is sustained by subsequent induction of Bmp2 by Tnfα. Bmp2 increases the magnitude of inflammation through induction of proinflammatory cell adhesion membrane proteins in endothelial cells. Grem2 is then induced as part of a negative feedback loop to inhibit Bmp2's proinflammatory activity and act as a barrier of inflammation at the infarct border zone ( Figure 8B ).
Discussion
Here we provide evidence for a new mechanism that regulates the magnitude and extent of the inflammatory response after MI. Specifically, we show that the BMP antagonist Grem2 is robustly and transiently induced after MI during the late Figure 7 . Gremlin 2 (Grem2) inhibits the proinflammatory effect of bone morphogenetic protein-2 (BMP2) on endothelial cells. A, Quantitative polymerase chain reaction (qPCR) analysis of whole-heart RNA samples isolated from wild-type (WT) mice at days 0, 1, 2, 3, 5, and 7 post myocardial infarction (MI) shows sequential induction of Tnfα, Bmp2, and Grem2 during the cardiac repair process. *P<0.05 and **P<0.01 (1-way ANOVA with Dunnett multiple comparisons test). n=3 for all time points. All data are presented as mean±SEM. B, qPCR analysis of RNA samples isolated from human microvascular endothelial cells (HMECs) at 4 (left) and 24 hours (right) after tumor necrotic factor α (TNFα) treatment shows TNFα induces E-SELECTIN and BMP2 expression. *P<0.05 (Student 2-tailed unpaired t test). n=3 per group. All data are presented as mean±SEM. C and D, qPRC analysis shows that BMP2 induces E-SELECTIN and GREM2 in HMECs after 24 hours. *P<0.05 and **P<0.01 (Student 2-tailed unpaired t test). n=3 per group. All data are presented as mean±SEM. E and F, qPCR analysis of RNA sample isolated from HMEC 24 hours after treatment with TNFα, BMP2, Grem2, and DMH1 in different combinations as indicated. E, TNFα and BMP2 together superinduce expression of E-SELECTIN. Grem2 specifically inhibits the BMP2 effect but has no effect on the E-SELECTIN induction by TNFα. F, Canonical BMP-signaling inhibitor DMH1 specifically inhibits the BMP2-induced E-SELECTIN. *P<0.05, **P<0.01, ****P<0.0001 (1-way ANOVA with Dunnett multiple comparison test). n=3 for all treatments. All data are presented as mean±SEM. G, Adhesion of human monocytes (THP-1 cells) to HMECs was measured after HMEC incubation with TNFα, BMP2, or in combination for 24 hours. TNFα and BMP2 induce binding of endothelial cells to monocytes. Grem2 specifically inhibits the BMP2 effect. *P<0.05 and ****P<0.0001 (1-way ANOVA with Bonferroni multiple comparison test). n=36. All data are presented as mean±SEM. ns indicates not significant.
by guest on September 23, 2017 http://circres.ahajournals.org/ Downloaded from inflammatory phase and the early proliferative phase of granulation tissue formation. Genetic loss and gain of function approaches revealed that Grem2 (1) controls the magnitude of the inflammatory cell infiltration, although not its long-term duration and, (2) acts as a molecular barrier to limit infiltration of inflammatory cells in the relatively healthy cardiac tissue adjacent to the infarct border zone. Grem2 administration during the inflammatory phase of cardiac tissue repair after MI decreases the number of inflammatory cells recruited to the infarct site. Our results further demonstrate that the antiinflammatory effects of Grem2 depend, at least in part, on suppression of canonical BMP signaling through inhibition of Smad1/5/8 phosphorylation within ventricular tissue at the infarct border zone. In agreement with this idea, administration of DMH1, a chemical inhibitor of canonical BMP signaling, rescued the inflammatory phenotype in Grem2 −/− mice. The effects of Grem2 in attenuating the inflammatory response correlate with a significant amelioration of ventricular function after MI, as evidenced by improved systolic and diastolic parameters in the TG Grem2 mice that overexpress Grem2 in cardiomyocytes. In contrast, cardiac function after MI further deteriorated over time in Grem2 −/− mice when compared with WT controls.
Grem2 seems to be an integral part of an orchestrated sequence of events that regulates the inflammatory response. Our results suggest that this sequence starts with induction of Bmp2 by Tnfα, which is released shortly after cardiac tissue injury. Bmp2 then acts synergistically or additively with Tnfα to further increase and sustain the induction of proinflammatory membrane proteins in endothelial cells, as the Tnfα effects decrease. The proinflammatory action of Bmp2 is then blocked by Grem2, which itself is induced by Bmp2, + , and F4/80 + cells in whole hearts was determined by flow cytometry at day 5 post MI. Grem2-injected mice have decreased inflammatory cell infiltration compared with controls. **P<0.01 and ***P<0.001 (1-way ANOVA with Bonferroni multiple comparisons test). Sham, n=3; vehicle, n=8; +Grem2, n=9. Bars represent mean±SEM. B, Model of the role of Grem2 during the inflammatory phase after MI. Cardiomyocyte cell death after ischemic injury causes induction of tumor necrotic factor α (TNFα), which directly stimulates expression of chemokines and endothelial membrane proteins to initiate inflammatory cell recruitment. TNFα also induces the expression of Bmp2 that further augments the proinflammatory phenotype of endothelial cells. Bmp2 in turn induces its own negative modulator Grem2 that inhibits the Bmp2-mediated inflammatory effects.
by guest on September 23, 2017 http://circres.ahajournals.org/ Downloaded from thus forming a negative regulatory loop. This concept is supported by the sequential induction of Tnfα, Bmp2, and Grem2 after MI, each approximately 24 hours apart. In vitro assays showing that Bmp2 acts on endothelial cells to promote cell adhesion of monocytes, the consistent changes in the number of inflammatory cells across a wide spectrum of various immune cell types, and histological analyses showing minimal changes in BMP signaling in infiltrating leukocytes all suggest that the main cellular targets of Grem2 in the regulation of the inflammatory response in the heart are the endothelial cells. However, at present, we cannot exclude that Grem2 may also affect inflammatory cell differentiation, activation, or mobilization before their recruitment in the infarct area.
Previous studies have linked BMP ligands to stimulation of the proinflammatory phenotype of endothelial cells and adhesion of leukocytes in response to shear stress in vitro. [49] [50] [51] [52] Likewise, BMP signaling has been associated with promotion of inflammation in models of atherosclerosis and with anemia caused by chronic inflammatory conditions. 51, 53, 54 Conversely, BMP antagonists, such as BMPER (BMP-binding endothelial regulator) and Noggin, can inhibit inflammation by reducing the expression of proinflammatory cell adhesion molecules, 51, 53, 55 and administration of chemical inhibitors of BMP signaling, such as LDN-193189 and dorsomorphin, reduced vascular inflammation and atherosclerosis. 52, 56, 57 Our data indicate that BMP signaling also plays an important role in the cardiac repair process after MI. Although it was known that BMP ligands might cause cardiomyocyte apoptosis, to our knowledge, ours is the first study to show that canonical BMP-signaling activation after MI controls the magnitude of the inflammatory response. Importantly, this is the first indication that induction of the BMP antagonist Grem2 in the heart after MI may be a critical mechanism in the suppression of the vascular proinflammatory phenotype, as a way to reduce and eventually stop recruitment of circulating leukocytes.
Grem2 protein is synthesized primarily in peri-infarct cardiomyocytes, a domain that overlaps both with the expression of BMP2 after MI and the area of p-Smad1/5/8, that is, canonical BMP-signaling activation. Histological analysis in Grem2 −/− mice suggests that Grem2 inhibits p-Smad activation. Some p-Smad1/5/8 persist in cardiomyocytes, even with Grem2 induction, which may be because of the presence of ligands, such as GDFs (growth differentiation factors) or activins that can induce Smad1/5/8 phosphorylation, but are not inhibited by Grem2. 26 Persistent activity suggests that additional canonical BMPsignaling inhibition may be required after MI to supplement Grem2. Previous reports have linked activation of BMP signaling to cardiomyocyte apoptosis 15 during the early stages of ischemia/reperfusion injury, as well as fibrosis and hypertrophy, 48 so Grem2 may have additional cardioprotective properties.
We have previously shown that Grem2 is necessary for cardiac asymmetry and atrial development in zebrafish. However, it seems that Grem2 is dispensable for mouse development. This result is not without precedent among BMPsignaling components. For example, single Bmp5, Bmp6, and Bmp7 knockout mice are viable, but double knockouts of either Bmp5/7 or Bmp6/7 are embryonic lethal because of cardiac developmental defects. [58] [59] [60] [61] It is likely that, as with Bmp ligands, there is redundancy among BMP antagonists in cardiac development. Such redundancy may also happen in the adult heart. Although Grem2 is the highest induced BMP antagonist after MI, the heart maintains expression of many BMP antagonists such as Chordin, Sost, Twsg1 and Dan. There are also low levels of Noggin expression. Sost does not inhibit Bmp2, and thus, it is unlikely that Sost plays a role in the inflammatory response, which is dominated by Bmp2 induction. Dan, Chordin, and Twsg1 are weaker antagonists than Grem2 and may not compensate for Grem2 in the periinfarct area, where Grem2 is prominently induced. 36, 37 It will be informative to generate double loss-of-function model by crossing the Grem2 −/− mice to mice with conditional inactivation of other BMP antagonists to directly test redundant functions during development or after injury.
Increased numbers of infiltrating immune cells or prolonged inflammation negatively impacts subsequent steps of cardiac repair and functional recovery. 4 Activated immune cells may continue to degrade matrix, impede angiogenesis, or affect myofibroblast proliferation and differentiation. However, clinical trials testing whether blocking inflammation improves outcomes have so far produced mixed results. For example, inhibitors of the complement system, TNFα, or integrins required for immune cell binding showed no significant improvement of infarct size and MI outcomes. 45, [62] [63] [64] [65] Glucocorticoids actually had severe adverse effects, likely because of their interference with functions that are essential for healing. 66 On the other hand, inhibitors of activated T cells, such as cyclosporine 67 and the P-selectin antagonist inclacumab, 68 did show promising results, indicating that moderating inflammation can be beneficial for cardiac repair after MI. However, the benefits of cyclosporine use after MI could not be replicated in a larger clinical trial. 69 The failure or modest success to reduce infarct size in patients with MI by targeting direct players of reparative inflammatory processes underscores the need to better understand the endogenous regulatory mechanisms that control the temporal and spatial extent of inflammation. Even if blocking overactive postinfarction inflammation does not affect the size of the infarct, it might moderate dilative remodeling.
Recent crystallographic evidence revealed that Grem2 folds into a unique tertiary shape that has not been described before. Specifically, Grem2 dimerizes in a head-to-tail manner, unlike the head-to-head pairing of Noggin. 20, 70 This head-to-tail arrangement gives rise to a concave and convex 3-dimensional structure, which precludes Grem2 from wrapping around BMP dimers as Noggin does. 20, 23, 70 We currently test whether this unique structural arrangement is also critical for the function of Grem2 in cardiac repair. Future biochemical analyses may identify critical structural motifs, which could be exploited to design molecules that mimic the biological effects of Grem2. Recognizing these mechanisms may offer novel insights in the cardiac healing process and provide new ways to regulate inflammation in a physiological manner. Moreover, because of the wide interest in regulating BMP signaling in bone fractures, osteoporosis, and cancer, many chemical compounds and peptides, to either promote or hinder BMP signaling, are being developed for clinical use. 71, 72 by guest on September 23, 2017 http://circres.ahajournals.org/
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Our findings may facilitate future repurposing of these new pharmacological resources for potential treatment of patients with MI to expand current strategies that aim to restore circulation to infarcted areas with thrombolytics and percutaneous interventions.
What Is Known?
• Recruitment of inflammatory cells is an early critical step in the repair of heart tissue after a myocardial infarction (MI).
• Although inflammatory cells are necessary to clear debris from dead cells, excessive inflammation after MI is correlated with adverse cardiac remodeling and poor prognosis.
• Bone morphogenetic proteins (BMPs), which are critical for heart development, are induced shortly after MI, but their role in heart repair is largely unknown.
What New Information Does This Article Contribute?
• The BMP-signaling inhibitor Gremlin 2 is a secreted protein that is transiently induced in infarct border cardiomyocytes at the end of the inflammatory phase after MI, at the site of BMP-signaling activation.
• BMP signaling contributes to the induction of cell adhesion membrane proteins in endothelial cells that capture and recruit inflammatory cells after MI.
• Grem2 gene inactivation intensifies BMP signaling, leading to a dramatic increase in the number of infiltrating inflammatory cells after MI and further deterioration of heart function, whereas Grem2 overexpression in the heart or injection of Grem2 protein shortly after MI attenuates inflammation and improves recovery.
Although unregulated inflammation has been linked to adverse effects in the heart, previous anti-inflammatory treatments in patients with MI have been mostly unsuccessful. The failure or modest success of clinical trials aiming to reduce infarct size in MI patients, by targeting direct players of the inflammatory processes, underscores the need to better understand the natural mechanisms that control inflammation in the injured heart tissue.
In this study, we provide evidence for a new mechanism that determines the magnitude and extent of the inflammatory response after MI. Specifically, our data show that tumor necrosis factor-α induction after MI initiates a transient inflammatory response, which is sustained by subsequent induction of the BMP ligand BMP2. BMP2 increases the magnitude of inflammation through upregulation of proinflammatory cell adhesion membrane proteins in endothelial cells. Grem2 is then induced by BMP2 as part of a negative feedback loop to inhibit the proinflammatory activity of canonical BMP signaling and act as a barrier to inflammation at the infarct border zone. Our findings suggest that BMP antagonists like Grem2 could attenuate inflammation and thereby improve heart recovery MI.
Supplemental Material Methods
Generation of genetically engineered Grem2 mice
In order to inactivate the Grem2 gene and generate Grem2 -/-mice, we first constructed an insertion vector containing two fragments from the Grem2 gene locus (fragments B and C, each The αMHC-Grem2 plasmid was generated by inserting the full-length Grem2 cDNA into the αMHC (Myh6) gene promoter-polyA hGH cloning vector 1 (kindly provided by Dr. J.
Robbins).
1
The αMHC-Grem2 transgenic (TG Grem2 ) mice were generated by pronuclear microinjection of the construct into fertilized oocytes at the TMESCSR. TG Grem2 mice and WT littermate controls were raised in C57BL/6 background.
Histological, molecular and flow cytometric analyses were conducted using male mice at 12-16 weeks of age fed with a normal chow diet.
Experimental myocardial infarction (MI) and administration of Grem2 protein and DMH1
Mice underwent open chest surgery, a 10-0 nylon suture was placed through the myocardium into the anterolateral left ventricular wall around the left anterior descending (LAD) artery and the vessel was permanently ligated. 2 Mice were euthanized at defined time points following surgery to obtain cardiac tissue for molecular, histological and flow cytometric analyses.
For injection of Grem2 protein, we synthesized, purified and measured activity as previously described. and water were added to the RNA solution and incubated at 40°C for 1 hour, followed by a 5 minute incubation at 95°C in order to inactivate enzyme activity. 1:100 of the final cDNA solution or ~20 ng served as template for quantitative Real Time PCR with GoTaq qPCR Master Mix (Promega) using a C1000 Thermal Cycler (BioRad) as previously described. 2,7 0.5 μM of Gapdh primers were included as an internal control and relative gene induction levels were determined using the 2 (-DDCt) formula. 8, 9 Experiments were done in triplicates. The sequences of gene-specific primers have been included in the Online Table III .
Immunofluorescence and immunohistochemistry analyses
For IF on cardiac tissue sections, freshly isolated hearts were perfused with 1X Phosphate 
Flow Cytometry
We prepared single cell suspensions of cardiac cells depleted of cardiomyocytes from freshly isolated whole hearts perfused with 1X PBS to remove blood cells. Next, hearts were digested with Collagenase D (2 mg/ml; Roche) and DNase I (100 μg/ml) in a solution of RPMI 1640 (Gibco) containing 10% FBS using an AUTOMacs Dissociator (Miltenyi Biotech), and then incubated at 37°C for 30 minutes in an orbital shaker to prepare single cell suspensions. The digested tissue was then passed through a 70-micron cell strainer and centrifuged at 500 g for 10 minutes. The cell pellet was suspended in 2 ml 1X PBS and centrifuged at 300 g for 5 minutes.
Two more centrifugation/wash steps followed, and the pellet was suspended in 100 μl of FACS buffer (1% BSA, 0.5% NaN 3 in 1X PBS). We then added 2 μl of Fc blocker (eBioscience) and cells were incubated for 10 minutes at 4°C to prevent non-specific antibody binding, then washed After incubation, cells were centrifuged at 300 g for 5 minutes and washed twice with 1 ml FACS buffer. 5 μl of 7-AAD (eBioscience) was added to 100 μl of the solution and incubated for 10 minutes at room temperature for live/dead staining. After 300 μl of FACS staining buffer was added, cell samples were analyzed by flow cytometry using the BD FACSCanto II cytometer. Total cell number was determined by adding 50 μl of counting beads (~49500-52000 beads per μl; Life Technologies). Flow-minus-one was used for gating. Low voltage gating was conducted in order to capture the counting bead population. All leukocyte populations were quantified within the CD45 + gate, and pro-inflammatory monocyte cell numbers were quantified within the F4/80 + gate. Data acquisition was completed using FloView.
Regarding flow cytometry of blood leukocytes, 100 µl of fresh heparinized blood was directly stained with 1.5 µl of each of the previously mentioned antibodies for 30 minutes at 4°C.
The samples were then washed with FACS buffer. 2 ml of red blood cell lysis buffer was applied per 100 μl of blood for 4 minutes at room temperature. Two additional rounds of washing and centrifugation at 1500g for 3 minutes followed. 7-AAD staining and incubation with primary and secondary antibodies was conducted as described above.
TTC Staining
Whole mouse hearts were isolated 24 hours post-MI, flash frozen and cut into 1 mm sections. The sections were incubated in 1.5%TTC at 37°C for 30 minutes and then fixed in 10%
formalin overnight, and finally imaged. ImageJ 1.46r (NIH) was used to outline infarct (white)
tissue. Infarct size is reported as a percentage of the total left ventricular (LV) area.
Cell culture
Human Microvascular Endothelial cells (HMECs) 10 were kindly provided by Dr. Sergey
Ryzhov. Cells used for experiments were between the third and fourth passages and cultured in 199 media (Gibco 11150) containing 15% FBS, 10 U/ml Heparin (Sigma), and 30 μg/ml endothelial cell growth supplement (Biomedical Technologies). Cells were grown in full growth serum and then seeded in 12-well plates. Prior to growth factor addition, cells were incubated with serum starvation media (same as normal media with 1% FBS) over night. Cells were subsequently treated with rhTNFα (R&D; 10 ng/ml), rhBMP2 (R&D; 100 ng/ml-200 ng/ml), Grem2 (100 ng/ml), and DMH1 (10μM) 11 300 ng/ml of BMP2, 100 ng/ml of Grem2 and 100ng/ml of TNFα were used alone or combination for 24 hours to treat either HMEC or THP-1 cells.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software. 
